title: Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
abstract: Previously, we described an orthotopic cholangiocarcinoma model based on bile duct inoculation of spontaneously-transformed low grade malignant rat BDE1 cholangiocytes (BDEsp cells) compared to high grade malignant erbB-2/neu- transformed BDE1 cholangiocytes (BDEneu cells) into the livers of syngeneic rats, which closely mimics clinical features of early versus advanced stages of the human cancer. We now used gene expression microarray together with quantitative real-time RT-PCR to profile genes differentially expressed in highly tumorigenic BDEneu cells and corresponding tumors compared to less aggressive tumorigenic BDEsp cells and tumors. Genes identified as being commonly overexpressed in parent BDEneu cells, tumors, and in a BDEneu tumor-derived cholangiocarcinoma cell line included Sox17, Krt20, Erbb2, and Sphk1 when respectively compared to BDEsp cells, tumors, and tumor-derived BDEsp cholangiocarcinoma cells. Muc1 was also prominently overexpressed in BDEneu cells and tumor-derived cholangiocarcinoma cells over that expressed in corresponding BDEsp cell lines. Periostin and tenascin-C, which were produced exclusively by cholangiocarcinoma-associated fibroblastic cells, were each significantly overexpressed in BDEneu tumors compared to BDEsp tumors. Interestingly, amphiregulin was representative of a gene found to be significantly underexpressed in vitro in BDEneu cells compared to BDEsp cells, but significantly overexpressed in BDEneu tumors compared to BDEsp tumors, and correlated with BDEneu cholangiocarcinoma progression in vivo. Our data support a unique animal model that recapitulates important molecular features of human cholangiocarcinoma progression, and may serve as a potentially powerful preclinical platform for identifying and rapidly testing novel molecular targeting strategies for cholangiocarcinoma therapy and/or prevention.
authors.affiliation: Department of Pathology, Division of Cellular and Molecular Pathogenesis, Virginia Commonwealth University School of Medicine, Richmond, VA 23298-0297, USA.
authors.forename: Catherine I
authors.initials: CI
authors.lastname: Dumur
authors.forename: Deanna J W
authors.initials: DJ
authors.lastname: Campbell
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: DeWitt
authors.forename: Regina A
authors.initials: RA
authors.lastname: Oyesanya
authors.forename: Alphonse E
authors.initials: AE
authors.lastname: Sirica
mesh_terms: D000818:Animals; D001650:Bile Duct Neoplasms / Q000235:genetics* / Q000473:pathology; D001653:Bile Ducts, Intrahepatic / Q000473:pathology*; D015153:Blotting, Western; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D018281:Cholangiocarcinoma / Q000235:genetics* / Q000473:pathology; D016000:Cluster Analysis; D004195:Disease Models, Animal; D020869:Gene Expression Profiling; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D051381:Rats; D018719:Erb-b2 Receptor Tyrosine Kinases; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases
references.citation: Hepatology. 2008 Apr;47(4):1178-90
references.pmid: 18081149
references.citation: J Hepatol. 1998 Oct;29(4):628-33
references.pmid: 9824272
references.citation: Mod Pathol. 2003 Oct;16(10):1019-27
references.pmid: 14559985
references.citation: Dig Liver Dis. 2005 Apr;37(4):269-74
references.pmid: 15788211
references.citation: Gastroenterology. 2005 Dec;129(6):2047-57
references.pmid: 16344070
references.citation: Int J Oncol. 2010 Feb;36(2):415-20
references.pmid: 20043076
references.citation: Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S68-78
references.pmid: 19896103
references.citation: Hepatology. 2010 Sep;52(3):975-86
references.pmid: 20607690
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Am J Pathol. 2006 Apr;168(4):1155-68
references.pmid: 16565491
references.citation: Clin Chem. 2004 Nov;50(11):1994-2002
references.pmid: 15364885
references.citation: Dev Cell. 2009 Jul;17(1):62-74
references.pmid: 19619492
references.citation: Nucleic Acids Res. 2003 Feb 15;31(4):e15
references.pmid: 12582260
references.citation: Cancer Res. 2010 Mar 1;70(5):1960-9
references.pmid: 20160031
references.citation: Exp Mol Pathol. 2010 Dec;89(3):248-59
references.pmid: 20655306
references.citation: Hum Pathol. 2008 May;39(5):710-9
references.pmid: 18329694
references.citation: Oncol Rep. 2009 Sep;22(3):649-57
references.pmid: 19639217
references.citation: Biochem Biophys Res Commun. 2010 Jan 1;391(1):357-63
references.pmid: 19913509
references.citation: Mol Cancer. 2010 Jan 24;9:13
references.pmid: 20096135
references.citation: Eur J Cancer. 2009 Jan;45(1):33-47
references.pmid: 18938071
references.citation: Hepatology. 2009 Dec;50(6):1861-70
references.pmid: 19821497
references.citation: Am J Pathol. 2003 Jul;163(1):217-29
references.pmid: 12819026
references.citation: Gastroenterology. 2009 Oct;137(4):1346-57
references.pmid: 19549530
references.citation: Biochem Biophys Res Commun. 2008 Jan 18;365(3):555-61
references.pmid: 18023415